Colorectal cancer: What should patients and families be told to lower the risk of colorectal cancer?

Surgical Oncology Clinics of North America

Volumn 19, Issue 4, 2010, Pages 693-710

  Moore, Harvey G ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; Colorectal cancer; Risk reduction; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CALCIUM; CELECOXIB; CURCUMIN; EFLORNITHINE; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ROFECOXIB; SELENIUM; SULINDAC; VITAMIN D;

ALCOHOL CONSUMPTION; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DIETARY FIBER; DIETARY INTAKE; DRUG EFFICACY; DRUG MECHANISM; FAMILY HISTORY; FRUIT; GASTROINTESTINAL SYMPTOM; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HUMAN; LIFESTYLE MODIFICATION; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; RECURRENT CANCER; RED MEAT; REVIEW; RISK REDUCTION; VEGETABLE;

COLORECTAL NEOPLASMS; HUMANS; PATIENT EDUCATION AS TOPIC; RISK FACTORS;

EID: 77957162470     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.06.002     Document Type: Review

References (118)

1. Center M.M., Jemal A., Smith R.A., et al. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009, 59(6):366-378.
2. World Health Organization Mortality Datebase Available at:, Accessed December 9, 2009. http://www-dep.iarc.fr/.
3. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249.
4. American Cancer Society Website Cancer Facts and Figures 2009 Available at:, Accessed December 16, 2009. http://www.cancer.org/downloads/STT/500809web.pdf.
5. National Cancer Society Cancer Control and Population Sciences Estimated US Cancer Prevalence Available at:, Accessed December 16, 2009. http://www.cancercontrol.cancer.gov/ocs/prevalence.
6. Whitlock E.P., Lin J.S., Liles E., et al. Screening for colorectal cancer: a targeted, updated systematic review for the US Preventive Services Task Force. Ann Intern Med 2008, 149(9):638-658.
7. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134(5):1570-1595.
8. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149(9):627-637.
9. Smith R.A., Cokkinides V., Brooks D., et al. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010, 60(2):99-119.
10. Baxter N.N., Goldwasser M.A., Paszat L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009, 150(1):1-8.
11. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329(27):1977-1981.
12. Lieberman D.A. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009, 361(12):1179-1187.
13. Imperiale T.F., Glowinski E.A., Lin-Cooper C., et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med 2008, 359(12):1218-1224.
14. Lieberman D.A., Weiss D.G., Harford W.V., et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007, 133(4):1077-1085.
15. Burt R.W., Barthel J.S., Dunn K.B., et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010, 8(1):8-61.
16. Schatzkin A., Freedman L.S., Dawsey S.M., et al. Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst 1994, 86(14):1053-1057.
17. O'Connell J.B., Maggard M.A., Liu J.H., et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003, 69(10):866-872.
18. Butterworth A.S., Higgins J.P., Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006, 42(2):216-227.
19. Glanz K., Grove J., Le Marchand L., et al. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev 1999, 8(7):635-639.
20. Rubin D.T., Gandhi R.K., Hetzel J.T., et al. Do colorectal cancer patients understand that their family is at risk?. Dig Dis Sci 2009, 54(11):2473-2483.
21. Butterly L.F., Goodrich M., Onega T., et al. Improving the quality of colorectal cancer screening: assessment of familial risk. Dig Dis Sci 2010, 55(3):754-760.
22. Sporn M.B. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976, 36:2699-2702.
23. Hawk E.T., Umar A., Viner J.L. Colorectal cancer chemoprevention-an overview of the science. Gastroenterology 2004, 126(5):1423-1447.
24. Garcia Rodriguez L.A., Huerta-Alvarez C. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. Epidemiology 2000, 11(4):376-381.
25. Garcia-Rodriguez L.A., Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001, 12(1):88-93.
26. Asano T.K., McLeod R.S. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2004, 2. CD004079.
27. Gann P.H., Manson J.E., Glynn R.J., et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 1993, 85(15):1220-1224.
28. Baron J.A., Cole B.F., Sandler R.S., et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003, 348(10):891-899.
29. Sandler R.S., Halabi S., Baron J.A., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003, 348(10):883-890.
30. Benamouzig R., Deyra J., Martin A., et al. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 2003, 125(2):328-336.
31. Giardiello F.M., Hamilton S.R., Krush A.J., et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993, 328(18):1313-1316.
32. Giardiello F.M., Yang V.W., Hylind L.M., et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002, 346(14):1054-1059.
33. Labayle D., Fischer D., Vielh P., et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991, 101(3):635-639.
34. Steinbach G., Lynch P.M., Phillips R.K., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000, 342(26):1946-1952.
35. Cook N.R., Lee I.M., Gaziano J.M., et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005, 294(1):47-55.
36. Sturmer T., Glynn R.J., Lee I.M., et al. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med 1998, 128(9):713-720.
37. Dube C., Rostom A., Lewin G., et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007, 146(5):365-375.
38. Flossmann E., Rothwell P.M. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007, 369(9573):1603-1613.
39. Logan R.F., Grainge M.J., Shepherd V.C., et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008, 134(1):29-38.
40. Baron J.A., Sandler R.S., Bresalier R.S., et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006, 131(6):1674-1682.
41. Grau M.V., Sandler R.S., McKeown-Eyssen G., et al. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst 2009, 101(4):267-276.
42. Chan A.T., Ogino S., Fuchs C.S. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 2009, 302(6):649-658.
43. Wolfe M.M., Lichtenstein D.R., Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999, 340(24):1888-1899.
44. Kelloff G.J., Lippman S.M., Dannenberg A.J., et al. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward. Clin Cancer Res 2006, 12(12):3661-3697.
45. Bresalier R.S., Sandler R.S., Quan H., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352(11):1092-1102.
46. Solomon S.D., McMurray J.J., Pfeffer M.A., et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005, 352(11):1071-1080.
47. Shpitz B., Giladi N., Sagiv E., et al. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 2006, 74(3-4):140-144.
48. Meyskens F.L., McLaren C.E., Pelot D., et al. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila Pa) 2008, 1(1):32-38.
49. Greenberg E.R., Baron J.A., Tosteson T.D., et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994, 331(3):141-147.
50. Albanes D., Malila N., Taylor P.R., et al. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control 2000, 11(3):197-205.
51. Baron J.A., Cole B.F., Mott L., et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst 2003, 95(10):717-722.
52. Clark L.C., Combs G.F., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276(24):1957-1963.
53. Reid M.E., Duffield-Lillico A.J., Sunga A., et al. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006, 118(7):1777-1781.
54. Lippman S.M., Klein E.A., Goodman P.J., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301(1):39-51.
55. Baron J.A., Beach M., Mandel J.S., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999, 340(2):101-107.
56. Bonithon-Kopp C., Kronborg O., Giacosa A., et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 2000, 356(9238):1300-1306.
57. Weingarten M.A., Zalmanovici A., Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2008, 1. CD003548.
58. Ishihara J., Inoue M., Iwasaki M., et al. Dietary calcium, vitamin D, and the risk of colorectal cancer. Am J Clin Nutr 2008, 88(6):1576-1583.
59. Larsson S.C., Bergkvist L., Rutegard J., et al. Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the Cohort of Swedish Men. Am J Clin Nutr 2006, 83(3):667-673. [quiz: 728-9].
60. Park Y., Leitzmann M.F., Subar A.F., et al. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med 2009, 169(4):391-401.
61. Park S.Y., Murphy S.P., Wilkens L.R., et al. Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Am J Epidemiol 2007, 165(7):784-793.
62. Wactawski-Wende J., Kotchen J.M., Anderson G.L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006, 354(7):684-696.
63. Woolcott C.G., Wilkens L.R., Nomura A.M., et al. Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2010, 19(1):130-134.
64. Wei M.Y., Garland C.F., Gorham E.D., et al. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17(11):2958-2969.
65. Yin L., Grandi N., Raum E., et al. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009, 30(2):113-125.
66. Huncharek M., Muscat J., Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer 2009, 61(1):47-69.
67. Kim Y.I. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen 2004, 44(1):10-25.
68. Kim Y.I. Role of folate in colon cancer development and progression. J Nutr 2003, 133:3731S-3739S.
69. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007, 297(21):2351-2359.
70. Ulrich C.M., Potter J.D. Folate and cancer-timing is everything. JAMA 2007, 297(21):2408-2409.
71. Luebeck E.G., Moolgavkar S.H., Liu A.Y., et al. Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev 2008, 17(6):1360-1367.
72. Sengupta S., Tjandra J.J., Gibson P.R. Dietary fiber and colorectal neoplasia. Dis Colon Rectum 2001, 44(7):1016-1033.
73. Fuchs C.S., Giovannucci E.L., Colditz G.A., et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999, 340(3):169-176.
74. Giovannucci E., Rimm E.B., Stampfer M.J., et al. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 1994, 54(9):2390-2397.
75. Peters U., Sinha R., Chatterjee N., et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003, 361(9368):1491-1495.
76. Bingham S.A., Day N.E., Luben R., et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003, 361(9368):1496-1501.
77. Bingham S.A., Norat T., Moskal A., et al. Is the association with fiber from foods in colorectal cancer confounded by folate intake?. Cancer Epidemiol Biomarkers Prev 2005, 14(6):1552-1556.
78. Park Y., Hunter D.J., Spiegelman D., et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005, 294(22):2849-2857.
79. Schatzkin A., Mouw T., Park Y., et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr 2007, 85(5):1353-1360.
80. Wakai K., Date C., Fukui M., et al. Dietary fiber and risk of colorectal cancer in the Japan collaborative cohort study. Cancer Epidemiol Biomarkers Prev 2007, 16(4):668-675.
81. Asano T., McLeod R.S. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2002, 2. CD003430.
82. Sansbury L.B., Wanke K., Albert P.S., et al. The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence. Am J Epidemiol 2009, 170(5):576-584.
83. Michels K.B., Edward G., Joshipura K.J., et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 2000, 92(21):1740-1752.
84. Voorrips L.E., Goldbohm R.A., van Poppel G., et al. Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study: the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol 2000, 152(11):1081-1092.
85. McCullough M.L., Robertson A.S., Chao A., et al. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control 2003, 14(10):959-970.
86. Koushik A., Hunter D.J., Spiegelman D., et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst 2007, 99(19):1471-1483.
87. van Duijnhoven F.J., Bueno-De-Mesquita H.B., Ferrari P., et al. Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2009, 89(5):1441-1452.
88. Michels K.B., Giovannucci E., Chan A.T., et al. Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Res 2006, 66(7):3942-3953.
89. Millen A.E., Subar A.F., Graubard B.I., et al. Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr 2007, 86(6):1754-1764.
90. de Kok T.M., van Maanen J.M. Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 2000, 463(1):53-101.
91. Bingham S.A., Pignatelli B., Pollock J.R., et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer?. Carcinogenesis 1996, 17(3):515-523.
92. de Vogel J., van-Eck W.B., Sesink A.L., et al. Dietary heme injures surface epithelium resulting in hyperproliferation, inhibition of apoptosis and crypt hyperplasia in rat colon. Carcinogenesis 2008, 29(2):398-403.
93. Larsson S.C., Wolk A. Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer 2006, 119(11):2657-2664.
94. Sandhu M.S., White I.R., McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001, 10(5):439-446.
95. Norat T., Lukanova A., Ferrari P., et al. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies. Int J Cancer 2002, 98(2):241-256.
96. Howard R.A., Freedman D.M., Park Y., et al. Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control 2008, 19(9):939-953.
97. Samad A.K., Taylor R.S., Marshall T., et al. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 2005, 7(3):204-213.
98. Harriss D.J., Atkinson G., Batterham A., et al. Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure time physical activity. Colorectal Dis 2009, 11(7):689-701.
99. Slattery M.L. Physical activity and colorectal cancer. Sports Med 2004, 34(4):239-252.
100. Caan B.J., Coates A.O., Slattery M.L., et al. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 1998, 22(2):178-184.
101. Kune G.A., Kune S., Watson L.F. Body weight and physical activity as predictors of colorectal cancer risk. Nutr Cancer 1990, 13(1-2):9-17.
102. Lin J., Zhang S.M., Cook N.R., et al. Body mass index and risk of colorectal cancer in women (United States). Cancer Causes Control 2004, 15(6):581-589.
103. Reeves G.K., Pirie K., Beral V., et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007, 335(7630):1134.
104. Sturmer T., Buring J.E., Lee I.M., et al. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006, 15(12):2391-2397.
105. Larsson S.C., Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007, 86(3):556-565.
106. Moghaddam A.A., Woodward M., Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007, 16(12):2533-2547.
107. Slattery M.L., Ballard-Barbash R., Edwards S., et al. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control 2003, 14(1):75-84.
108. Wang Y., Jacobs E.J., Teras L.R., et al. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women. Cancer Causes Control 2007, 18(8):793-799.
109. Hoffmeister M., Raum E., Winter J., et al. Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany. Br J Cancer 2007, 97(11):1486-1492.
110. Kim Y., Kim Y., Lee S. An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol 2009, 9:4.
111. Jacobs E.T., Ahnen D.J., Ashbeck E.L., et al. Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009, 169(6):657-666.
112. Jacobs E.T., Martinez M.E., Alberts D.S., et al. Association between body size and colorectal adenoma recurrence. Clin Gastroenterol Hepatol 2007, 5(8):982-990.
113. Paskett E.D., Reeves K.W., Rohan T.E., et al. Association between cigarette smoking and colorectal cancer in the Women's Health Initiative. J Natl Cancer Inst 2007, 99(22):1729-1735.
114. Botteri E., Iodice S., Bagnardi V., et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008, 300(23):2765-2778.
115. Chaiter Y., Gruber S.B., Ben-Amotz A., et al. Smoking attenuates the negative association between carotenoids consumption and colorectal cancer risk. Cancer Causes Control 2009, 20(8):1327-1338.
116. Moskal A., Norat T., Ferrari P., et al. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 2007, 120(3):664-671.
117. Mizoue T., Inoue M., Wakai K., et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol 2008, 167(12):1397-1406.
118. Ferrari P., Jenab M., Norat T., et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2007, 121(9):2065-2072.